Table 4.
Preoperative biomarker levels in patients with and without a thrombus
| Thrombus | No thrombus | p value | |
|---|---|---|---|
| ATIII (%) | 48.3 ± 19.2 | 92.5 ± 26.4 | 0.01 |
| D-dimer (ng/ml) | 443.8 ± 542 | 194.9 ± 113.2 | 0.61 |
| Protein C (%) | 35.8 ± 24.1 | 45.8 ± 21 | 0.38 |
| Protein S (%) | 33.9 ± 8.8 | 41.9 ± 12 | 0.17 |
| TFPI (pg/ml) | 16,544.4 ± 8,425.9 | 10,408.9 ± 2,369.7 | 0.09 |
| TAT (ng/ml) | 19.5 ± 8.3 | 22.8 ± 8.2 | 0.52 |
| PAI-1 (ng/ml) | 21.1 ± 23.8 | 8.7 ± 6.2 | 0.22 |
| tPA (ng/ml) | 13.6 ± 8.2 | 5.8 ± 3.9 | 0.02 |
| sCD40L (ng/ml) | 69.3 ± 24.4 | 74.9 ± 23 | 0.44 |
| Urinary TBX (ng/mg creatinine) | 7.9 ± 7.1 | 5.8 ± 7.7 | 0.77 |
Data are presented as means ± standard deviations
ATIII antithrombin III, TFPI tissue factor pathway inhibitor, TAT thrombin antithrombin complex, PAI-1 plasminogen activator inhibitor-1, tPA tissue plasminogen activator, sCD40L soluble CD 40 ligand, TBX thromboxane B2